Advertisement

Topics

With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up

08:49 EST 8 Nov 2017 | Xconomy

Exonics Therapeutics, one of the players in an emerging race to use gene therapy or gene editing techniques to treat Duchenne muscular dystrophy, has just landed a big round of funding to take its first treatment into clinical testing. The Cambridge, MA, company, seeded last year by a subsidiary of the nonprofit group CureDuchenne, will […]

Original Article: With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up

NEXT ARTICLE

More From BioPortfolio on "With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...